A therapeutic target for smoking-associated lung cancer (Q39619712)

13 September 2017

A therapeutic target for smoking-associated lung cancer (English)

1 reference

13 September 2017

1 reference

Nicholas C Turner

1

1 reference

PubMed ID

21160076

13 September 2017

Michael J Seckl

series ordinal

2

1 reference

PubMed ID

21160076

13 September 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

Science Translational Medicine

13 September 2017

1 reference

13 September 2017

2

1 reference

13 September 2017

62

1 reference

13 September 2017

62ps56

1 reference

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

13 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

High-resolution genomic profiles of human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Potential for targeting the fibroblast growth factor receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Comprehensive profiling of 8p11-12 amplification in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001942

10.1126/SCITRANSLMED.3001942

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

21160076